MDT

86.14

-0.25%↓

A

114.53

+0.54%↑

VEEV

172.83

-1.41%↓

HQY

83.37

+0.23%↑

PHR.US

8.39

+0.72%↑

MDT

86.14

-0.25%↓

A

114.53

+0.54%↑

VEEV

172.83

-1.41%↓

HQY

83.37

+0.23%↑

PHR.US

8.39

+0.72%↑

MDT

86.14

-0.25%↓

A

114.53

+0.54%↑

VEEV

172.83

-1.41%↓

HQY

83.37

+0.23%↑

PHR.US

8.39

+0.72%↑

MDT

86.14

-0.25%↓

A

114.53

+0.54%↑

VEEV

172.83

-1.41%↓

HQY

83.37

+0.23%↑

PHR.US

8.39

+0.72%↑

MDT

86.14

-0.25%↓

A

114.53

+0.54%↑

VEEV

172.83

-1.41%↓

HQY

83.37

+0.23%↑

PHR.US

8.39

+0.72%↑

Search

Medpace Holdings Inc

Gesloten

SectorGezondheidszorg

489.22 2.24

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

480.15

Max

491.37

Belangrijke statistieken

By Trading Economics

Inkomsten

24M

135M

Verkoop

49M

708M

K/W

Sectorgemiddelde

30.144

56.063

Winstmarge

19.074

Werknemers

6,200

EBITDA

14M

164M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+12.59% upside

Dividenden

By Dow Jones

Volgende Winsten

22 apr 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-3.5B

13B

Vorige openingsprijs

486.98

Vorige sluitingsprijs

489.22

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

Medpace Holdings Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 okt 2025, 15:15 UTC

Winsten

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back -- Barrons.com

Peer Vergelijking

Prijswijziging

Medpace Holdings Inc Prognose

Koersdoel

By TipRanks

12.59% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 518.25 USD  12.59%

Hoogste 582 USD

Laagste 419 USD

Gebaseerd op 9 Wall Street-analisten die 12-maands prijsdoelen bieden voor Medpace Holdings Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

9 ratings

4

Buy

5

Hold

0

Sell

Technische score

By Trading Central

300 / 302.88Steun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Strong Bearish Evidence

Lange Termijn

Weak Bearish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
help-icon Live chat